Mandate

Vinge advises EQT Infrastructure IV on its acquisition of IP-Only Group AB

June 11, 2019 M&A

IP-Only owns and operates approximately 16,000 km of fiber network that, together with leased infrastructure, covers 230 of 290 municipalities in Sweden.

Vinge has advised EQT Infrastructure IV in connection with entering into an agreement to acquire 100% of the shares in IP-Only Group AB at an enterprise value of SEK 18.25 billion (EUR 1.7 billion), plus an earn-out of up to SEK 1 billion (EUR 94 million).
 
IP-Only, through its Consumer division, started a nationwide roll-out of fiber to residential customers in 2014. Today IP-Only provides wholesale fiber access services to more than 200,000 households and has a large pipeline of additional homes in progress of being delivered. EQT Infrastructure will support IP-Only in its continued contribution to achieving the Swedish Government’s broadband targets, meaning that 98 percent of the Swedish population will have broadband access by the end of 2025. 
 
The transaction is expected to close in June 2019.
 
Vinge’s team consisted of Daniel Rosvall, Karl Klackenberg, Desirée Sjöblom, Milad Kamali and Isabelle Jengsell (M&A), Louise Brorsson Salomon and Axel Jansson (Banking and Financing), Mathilda Persson and Lisa Hörnqvist (Commercial Agreements and IT), Sebastian Örndahl (Commercial Agreements, Competition and Regulatory), Kristoffer Larson (Real Property) and Daniel Wendelsson (Public Procurement).
 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026